Darbepoetin Alfa vs Epoetin Alfa
Head-to-head comparison of Darbepoetin Alfa (Darbepoetin alfa, recombinant human erythropoiesis-stimulating protein) and Epoetin Alfa (Recombinant human erythropoietin alfa) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Darbepoetin Alfa | Epoetin Alfa |
|---|---|---|
| Category | Muscle & Performance | Muscle & Performance |
| Full Name | Darbepoetin alfa, recombinant human erythropoiesis-stimulating protein | Recombinant human erythropoietin alfa |
| Molecular Weight | ≈37,000 Da | ≈30,400 Da |
| Half-Life | ~21 h IV; ~49 h SC | ~4-13 h IV; ~20-30 h SC |
| Amino Acids | 165 | 165 |
| Typical Dose | 0.45 mcg/kg weekly SC or 0.75 mcg/kg every 2 weeks | 50-100 IU/kg SC 3x weekly or 40,000 IU SC weekly |
| Route | Subcutaneous/IV | Subcutaneous/IV |
| Purity | ≥98% | ≥98% |
| Studies Count | 210 | 320 |
| Research Status | Clinical | Clinical |
Darbepoetin Alfa Benefits
- ✓longer-acting erythropoiesis
- ✓stable hemoglobin
- ✓increased oxygen delivery
- ✓may improve aerobic capacity
Epoetin Alfa Benefits
- ✓raises hemoglobin
- ✓increases oxygen-carrying capacity
- ✓may increase VO2 max
- ✓improves time-to-exhaustion
Darbepoetin Alfa Dosing
0.45 mcg/kg weekly SC|0.75 mcg/kg every 2 weeks SC|Dose-adjust to hemoglobin response
Epoetin Alfa Dosing
50-100 IU/kg subcutaneous 3x weekly|40,000 IU subcutaneous weekly|Titrate to hemoglobin target under medical supervision
Darbepoetin Alfa Side Effects
- ⚠hypertension
- ⚠thromboembolism
- ⚠headache
Epoetin Alfa Side Effects
- ⚠hypertension
- ⚠thrombosis
- ⚠polycythemia
Research Overview
Darbepoetin Alfa
Clinical studies show durable hemoglobin correction with less frequent dosing than epoetin alfa. The endurance benefit, where present, would come from improved oxygen-carrying capacity rather than a direct ergogenic pathway.
Epoetin Alfa
Human studies in anemia and performance-related settings show that increasing red-cell mass can improve aerobic capacity and endurance. It remains heavily regulated because excessive erythropoiesis raises thrombotic and cardiovascular risk.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.